Alembic gets USFDA nod for generic pain-relief medication

The company's product is therapeutically equivalent to Roche Palo Alto LLC's Toradol Injection. Ketorolac Tromethamine is indicated for the short-term management of moderately severe acute pain in adult patients.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news